期刊文献+

基因修饰T淋巴细胞在肿瘤免疫治疗中的应用 被引量:2

Research progress on genetically-engineered T lymphocytes in anti-tumor immunotherapy
下载PDF
导出
摘要 基因修饰T细胞是指利用基因工程方法对T细胞进行基因修饰,通过提高T细胞对抗原的结合能力、增强活化信号的疗复耐转导、延长T细胞在体内的生存时间、增加肿瘤组织中活化T细胞的数量以及改进基因免疫治疗的安全性,最终达到提高T细胞肿瘤免疫治疗的疗效。尽管该方法还存在许多问题,但是最近几年经基因修饰T细胞过继性免疫治疗在基础与临床研究方面均取得了可喜的进展。随着人们对肿瘤免疫研究的深入和基因工程技术的快速发展,基因修饰的T细胞在肿瘤免疫治疗中将有广阔的应用前景。
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 2008年第3期292-295,共4页 Chinese Journal of Cancer Biotherapy
基金 广东省自然科学基金(No.05001750)~~
  • 相关文献

参考文献28

  • 1Rosenberg SA, Restifo NP,Yang JC, et al. Adoptive cell transfer: a clinical path to effective cancer immunotherapy [ J ]. Nat Rev Cancer,2008,8 ( 4 ) :299 -308.
  • 2Leen AM, Rooney CM ,Foster AE, et al. Improving T cell therapy for cancer[ J]. Annu Rev Immunol, 2007, 25: 243-265.
  • 3Rosenberg SA, Dudley ME. Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes[ J]. Proc Nat1 Acad Sci USA, 2004, 101 (2): 14639- 14645.
  • 4Morgan RA,Dudley ME,Wunderlich JR, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes [ J ]. Science, 2006, 314(5796) : 126-129.
  • 5Cohen C J, Zheng Z, Bray R, et ol. Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine Anti-p53 TCR[ J]. J Immunol, 2005, 175(9) : 5799-5808.
  • 6Zhao Y,Zheng Z, Robbins PF, et al. Primary human lymphocytes transduced with NY-ESO-I antigen-specific TCR genes recognize and kill diverse human tumor cell lines[J]. J Immunol, 2005,174 (7) : 4415-4423.
  • 7Abad JD, Wrzensinski C, Overwijk W, et al. T-cell receptor gene therapy of established tumors in a murine melanoma model[ J ]. J immunother, 2008, 31 ( 1 ) : 1-6.
  • 8Cohen CJ, Li YF, El-Gamil M, et ol. Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond[ J]. Cancer Res, 2007, 67(8) : 3898-38903.
  • 9van der Veken LT, Hagedoorn RS, van Loenen MM,et al. Alpha beta T-cell receptor engineered gamma delta T cells mediate effective antileukemic reactivity[J]. Cancer Res, 2006, 66(6) : 3331- 3337.
  • 10Eshhar Z. The T-body approach: redirecting T cells with antibody specificity[J]. Handb Exp Pharmacol, 2008, 181: 329-342.

同被引文献65

  • 1张瑞萍,云琳,陆斌,彭玲,周倩,王浩,郭亚军.嵌合T细胞受体的构建及其在T淋巴细胞表面的表达和体外抗肿瘤功能的检测[J].中华实验外科杂志,2006,23(5):609-611. 被引量:3
  • 2Schreiber RD, Old U, Smyth MJ. Cancer immunoediting: In-tegrating immunity ’ s roles in cancer suppression and promotion[J]. Science,2011,331(6024) : 1565-1570.
  • 3Cheadle EJ,Sheard V,Hombach AA, et al. Chimeric antigen re-ceptors for T-cell based therapy [ J]. Methods Mol Biol, 2012,907: 645-666.
  • 4Rosenberg SA, Restifo NP, Yang JC, et al. Adoptive cell trans-fer: A clinical path to effective cancer immunotherapy [ J] . NatRev Cancer, 2008, 8(4) : 299-308.
  • 5Gattinoni L, Lugli E, Ji Y, et al. A human memory T cell subsetwith stem cell-like properties [ J]. Nat Med,2011,17 (10 ):1290-1297.
  • 6Gross G, Waks T, Eshhar Z. Expression of immunoglobulin-T-cellreceptor chimeric molecules as functional receptors with antibody-type specificity [ J]. Proc Natl Acad Sci U S A, 1989, 86(24):10024-10028.
  • 7Ahmed N, Ratnayake M, Savoldo B,et al. Regression of experi-mental medulloblastoma following transfer of HE R2-specific Tcells [J]. Cancer Res, 2007, 67(12) : 5957-5964.
  • 8Chmielewski M, Hahn 0,Rappl G, et al. T cells that target car-cinoembryonic antigen eradicate orthotopic pancreatic carcinomaswithout inducing autoimmune colitis in mice [ J]. Gastroenterolo-gy, 2012, 143(4) :1095-1107.
  • 9Guest RD, Hawkins RE,Kirillova N,et al. The role of extracel-lular spacer regions in the optimal design of chimeric immune re-ceptors :Evaluation of four different scFvs and antigens [ J]. JImmunother, 2005,28(3) : 203-211.
  • 10Bridgeman JS, Hawkins RE, Bagley S, et al. The optimal antigenresponse of chimeric antigen receptors harboring the CD3zetatransmembrane domain is dependent upon incorporation of the re-ceptor into the endogenous TCR/CD3 complex [ J]. J Immunol,2010, 184(12) : 6938-6949.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部